Position statement on the use of biosimilars in inflammatory bowel disease. Swiss Medical Weekly, [S. l.], v. 149, n. 4950, p. w20148, 2019. DOI: 10.4414/smw.2019.20148. Disponível em: https://smw.ch/index.php/smw/article/view/2696. Acesso em: 13 dec. 2025.